Elite in Vitrectomy

Dr. Hugo Quiroz-Mercado

Ophthalmology
777 Bannock St, Mc 7782, 
Denver, CO 
Elite in Vitrectomy
777 Bannock St, Mc 7782, 
Denver, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hugo Quiroz-Mercado is an Ophthalmologist in Denver, Colorado. Dr. Quiroz-Mercado is rated as an Elite provider by MediFind in Vitrectomy. His top areas of expertise are Retinopathy of Prematurity, Retinal Detachment, Blepharitis, Vitrectomy, and Cataract Removal.

His clinical research consists of co-authoring 94 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 19 articles and participated in 2 clinical trials in the study of Vitrectomy.

Specialties
Ophthalmology
Licenses
Ophthalmology in CO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

777 Bannock St, Mc 7782, Denver, CO 80204

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Intravitreal Bevacizumab for the Treatment of Central Serous Chorioretinopathy
Enrollment Status: Withdrawn
Publish Date: June 05, 2024
Intervention Type: Drug
Study Drug: Bevacizumab
Study Phase: Phase 2/Phase 3
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Evaluation of Efficacy of Intravitreal Bevacizumab Retreatments
Enrollment Status: Terminated
Publish Date: June 03, 2024
Intervention Type: Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 3
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Pars Plana Vitrectomy and Bevacizumab for the Treatment of Diffuse Diabetic Macular Edema (A Pilot Study)
Enrollment Status: Terminated
Publish Date: May 31, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure
Study Phase: Phase 3
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Does Avastin Change Evolution in Juxtafoveal Telangiectasias?
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Drug: Bevacizumab
Study Phase: Phase 3
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Intravitreal Bevacizumab vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-year Prospective, Contralateral Eye Study
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Procedure, Drug
Study Drug: Intravitreal Injection of Bevacizumab
Study Phase: Phase 2/Phase 3
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)
Enrollment Status: Withdrawn
Publish Date: May 30, 2024
Intervention Type: Drug, Procedure
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

97 Total Publications

Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Safety and Efficacy of a Mesenchymal Stem Cell Secretome Therapy (KPI-012) for Persistent Corneal Epithelial Defects: A Phase 1b Trial.
Journal: Current therapeutic research, clinical and experimental
Published: December 13, 2024
Similar Doctors
Distinguished in Vitrectomy
Dr. Murtaza K. Adam
Ophthalmology
Distinguished in Vitrectomy
Dr. Murtaza K. Adam
Ophthalmology

Colorado Retina Associates, PLLC

850 Englewood Pkwy, Suite 200, 
Englewood, CO 
 (5.1 miles away)
303-261-1600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Murtaza Adam is an Ophthalmologist in Englewood, Colorado. Dr. Adam is rated as a Distinguished provider by MediFind in Vitrectomy. His top areas of expertise are Endophthalmitis, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, and Vitrectomy. Dr. Adam is currently accepting new patients.

Distinguished in Vitrectomy
Dr. Naresh Mandava
Ophthalmology
Distinguished in Vitrectomy
Dr. Naresh Mandava
Ophthalmology

University Physicians Incorporated

12605 E 16th Ave, Uchealth Anschutz Medical, 
Aurora, CO 
 (8.0 miles away)
720-848-0000
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Naresh Mandava is an Ophthalmologist in Aurora, Colorado. Dr. Mandava is rated as an Elite provider by MediFind in Vitrectomy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, Vitrectomy, and Cataract Removal. Dr. Mandava is currently accepting new patients.

Advanced in Vitrectomy
Dr. Jesse M. Smith
Ophthalmology
Advanced in Vitrectomy
Dr. Jesse M. Smith
Ophthalmology

University Physicians Incorporated

1665 Aurora Ct, 
Aurora, CO 
 (8.1 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jesse Smith is an Ophthalmologist in Aurora, Colorado. Dr. Smith is rated as a Distinguished provider by MediFind in Vitrectomy. His top areas of expertise are Diabetic Retinopathy, Retinal Vein Occlusion, Retinal Artery Occlusion, Vitrectomy, and Cataract Removal. Dr. Smith is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Quiroz-Mercado's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 14 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile